Sells laboratory instruments, software, services and consumables to pharmaceutical and biopharmaceutical companies, clinical and research laboratories, and industrial testing organizations.
10-K for FY2025, filed Dec 22, 2025Our Life Sciences and Diagnostics Markets segment is comprised of seven areas of activity. We provide specialty contract development and…View ↗
Our Life Sciences and Diagnostics Markets segment sells primarily into the pharmaceutical and biopharmaceutical, diagnostics and clinical…View ↗
The Chemicals and Advanced Materials Market. Our products and solutions are used throughout the chemicals sector in the development…View ↗
Large accounts are served primarily through direct sales; sales agents extend coverage to smaller accounts, with resellers, distributors and online sales providing additional routes. Consumables also sell through distributors and online sales.
10-K for FY2025, filed Dec 22, 2025We deploy a multi-channel approach, marketing products to our customers through direct sales, electronic commerce, resellers…View ↗
We deploy a multi-channel approach, marketing services to our customers through direct sales, electronic commerce, resellers…View ↗
We deploy a multi-channel approach, marketing products to our customers through direct sales, electronic commerce, resellers…View ↗
Yes. It kept 19 cents of every revenue dollar as net income in FY2025 and turned 17 cents into free cash flow.
10-Q for Q3 FY2026, filed Sep 1, 2026
Open tableView ↗
8-K, filed Sep 8, 2026
(b) On September 2, 2026, Boon Hwee Koh, Chairperson of the Board of Directors (the "Board") of Agilent Technologies, Inc. (the "Company")…View ↗
8-K, filed Aug 26, 2026
Fiscal year 2026 revenue is now expected in the range of $7.49 billion to $7.51 billion, representing a range of up 7.8% to 8.1% reported…View ↗
Portfolio reorganization
The older report placed chromatography products in life sciences and applied markets and treated diagnostics and genomics as a separate business. The business now combines these into Life Sciences and Diagnostics Markets, while moving lab software, automation, chemistries and supplies into CrossLab.
10-K for FY2022, filed Dec 21, 2022 10-K for FY2025, filed Dec 22, 2025Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable…View ↗
Our life sciences and applied markets business provides application-focused solutions that include instruments and software that enable…View ↗
We provide informatics and scientific software for instrument control, data acquisition, data analysis, secure storage of results, and…View ↗
Laboratory Automation and RoboticsView ↗
Chemistries and SuppliesView ↗
In November 2024, we announced a change in our organizational structure to support our market-focused, customer-centric strategy. Our…View ↗
Competes with AB Sciex, Avecia, Bruker, Leica Biosystems, Roche Ventana Medical Systems, Shimadzu, Thermo Fisher Scientific, Twist Bioscience, and Waters
10-K for FY2025, filed Dec 22, 2025The analytical product sets in the Life Sciences and Diagnostics Markets in which we compete are characterized by evolving industry…View ↗
Loading...